Stanford Medicine has treated its first patient in their new upright proton therapy facility. This milestone validates the Leo Cancer Care upright patient positioning platform, paving the way for integrating TibaRay's Galactica™ linac technology.
Cancer is the leading cause of death worldwide. To change that, radiotherapy must evolve–fast.
Treatments that take minutes allow tumors to shift and patients to move, reducing precision and limiting curative dose.
Normal organs are injured by radiation, forcing clinicians to hold back from the intensity needed for cure.
Most of the world cannot afford enough of today’s machines, leaving millions without lifesaving treatment.
All enabled by our revolutionary Galactica™ linear accelerator platform.
Our core accelerator platform powers breakthroughs across industries.
Commercial agreement validates clinical-market pull and partner confidence.
Stanford's first patient treatment using Leo Cancer Care's upright platform validates the clinical positioning technology TibaRay integrates with. Learn More
Portable high-performance imaging development for Government customers.
Novel RF components.
Selected through Lehigh University’s Startup Academy, TibaRay was showcased on the iconic seven-story Nasdaq Tower in New York's Times Square.
Beaming our mission of Curing Cancer in a FLASH™ across one of the world's most visible stages marks a major milestone in our commercial momentum and global recognition.
Help us bring FLASH radiotherapy to patients worldwide.
View Investment Proposal
